Phentermine-Associated Pseudomembranous Colitis
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - July 1, 2021 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study
by Tae-Jin Song, Yoonkyung Chang, Jimin Jeon, Jinkwon Kim
We investigated the association between oral hygiene indicators of periodontitis, tooth loss, and tooth brushing on the longitudinal fasting glucose level in non-diabetic subjects. Using a nationwide health screening database in Korea, we included non-diabetic individuals who received a health scr eening program with oral health check in 2009–2010. We constructed a linear mixed model for the longitudinal data of fasting glucose from the baseline to 2015. During the 4.84-year of median follow-up, 91,963 individuals (mean age 56.2 at baseline) underwent 392,780 hea...
Source: PLoS One - June 29, 2021 Category: Biomedical Science Authors: Tae-Jin Song Source Type: research
Semaglutide (Wegovy) for Weight Loss
Date: July 12, 2021
Issue #:
1628Summary:
The injectable glucagon-like peptide-1 (GLP-1)
receptor agonist semaglutide, previously approved
by the FDA asOzempic to treat type 2 diabetes and
to reduce the risk of major adverse cardiovascular
events in adults with type 2 diabetes and established
cardiovascular disease, has now been approved in
a higher dose asWegovy (Novo Nordisk) for chronic
weight management in adults with or without type 2
diabetes who have a body mass index (BMI) ≥30 kg/m2
or a BMI ≥27 kg/m2 and ≥1 weight-related comorbidity
(e.g., hypertension, dyslipidem...
Source: The Medical Letter - June 15, 2021 Category: Drugs & Pharmacology Authors: admin Tags: Liraglutide Phentermine Qsymia Saxenda semaglutide topiramate type 2 diabetes Wegovy Weight loss Source Type: research
Exenatide, dapagliflozin or phentermine/topiramate differentially affect metabolic profiles in polycystic ovary syndrome
CONCLUSION: Dual therapy with EQW/DAPA was superior to either alone, DAPA/MET and PHEN/TPM in terms of clinical and metabolic benefits in this patient population.PMID:34097062 | DOI:10.1210/clinem/dgab408 (Source: The Journal of Clinical Endocrinology and Metabolism)
Source: The Journal of Clinical Endocrinology and Metabolism - June 7, 2021 Category: Endocrinology Authors: Karen E Elkind-Hirsch N Chappell Ericka Seidemann John Storment Drake Bellanger Source Type: research
Exenatide, dapagliflozin or phentermine/topiramate differentially affect metabolic profiles in polycystic ovary syndrome
CONCLUSION: Dual therapy with EQW/DAPA was superior to either alone, DAPA/MET and PHEN/TPM in terms of clinical and metabolic benefits in this patient population.PMID:34097062 | DOI:10.1210/clinem/dgab408 (Source: The Journal of Clinical Endocrinology and Metabolism)
Source: The Journal of Clinical Endocrinology and Metabolism - June 7, 2021 Category: Endocrinology Authors: Karen E Elkind-Hirsch N Chappell Ericka Seidemann John Storment Drake Bellanger Source Type: research
Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
CONCLUSIONS: Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage. However, it increased the risk of nervous system-related adverse events.PMID:33864346 | DOI:10.1002/oby.23152 (Source: Obesity)
Source: Obesity - April 17, 2021 Category: Eating Disorders & Weight Management Authors: Xiang-Guo Lei Jia-Qi Ruan Chen Lai Ziyi Sun Xi Yang Source Type: research
Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
CONCLUSIONS: Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage. However, it increased the risk of nervous system-related adverse events.PMID:33864346 | DOI:10.1002/oby.23152 (Source: Obesity)
Source: Obesity - April 17, 2021 Category: Eating Disorders & Weight Management Authors: Xiang-Guo Lei Jia-Qi Ruan Chen Lai Ziyi Sun Xi Yang Source Type: research
Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
CONCLUSIONS: Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage. However, it increased the risk of nervous system-related adverse events.PMID:33864346 | DOI:10.1002/oby.23152 (Source: Obesity)
Source: Obesity - April 17, 2021 Category: Eating Disorders & Weight Management Authors: Xiang-Guo Lei Jia-Qi Ruan Chen Lai Ziyi Sun Xi Yang Source Type: research
Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
CONCLUSIONS: Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage. However, it increased the risk of nervous system-related adverse events.PMID:33864346 | DOI:10.1002/oby.23152 (Source: Obesity)
Source: Obesity - April 17, 2021 Category: Eating Disorders & Weight Management Authors: Xiang-Guo Lei Jia-Qi Ruan Chen Lai Ziyi Sun Xi Yang Source Type: research
